Showing results (571-580 of 948) with videos related to
Sort By:
Pageof 95
British Journal of Clinical Pharmacology|December 1, 1985
Haemodynamic dose-response effects of intravenous nisoldipine in coronary artery diseaseB Silke, M A Frais, P Muller, et al.Vaccine|January 31, 2007
Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005Claude P Muller, Jacques R Kremer, Jennifer M Best, et al.BMC Structural Biology|April 9, 2009
Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection controlVeljko Veljkovic, Nevena Veljkovic, Claude P Muller, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 1, 1996
[Neonatal rhinopharyngeal obstruction due to craniopharyngioma]D Cheddadi, S Triki, S Gallet, et al.Plos One|November 10, 2016
Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from ChinaVeljko Veljkovic, Nevena Veljkovic, Slobodan Paessler, et al.Plos One|April 16, 2015
Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDRAntony P Black, Keooudomphone Vilivong, Phonethipsavanh Nouanthong, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseasesP Seeman, N H Bzowej, H C Guan, et al.FEBS Letters|April 26, 1993
A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptidesJ D Corness, L L Demchyshyn, P Seeman, et al.Neuromuscular Disorders : NMD|April 17, 2007
GDAP1 mutations in Czech families with early-onset CMTL Baránková, E Vyhnálková, S Züchner, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1996
Radioreceptor binding profile of the atypical antipsychotic olanzapineF P Bymaster, D O Calligaro, J F Falcone, et al.Pageof 95